Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance

Oscar Health IncTrade
iShares 20 Plus Year Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while iShares 20 Plus Year Treasury Bond ETF trades at $77.98 (market cap $47.61B). The key difference: iShares 20 Plus Year Treasury Bond ETF is far larger — about 4.7× Oscar Health Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.

OSCRTLT
Market Cap
$10.22B$47.61B
Volume
4,123,39449,263,490
Sector
HealthFixed Income
52-Week High
$33.81$92.06
52-Week Low
$10.85$77.11
Typical Hold Time
15 Days83 Days
Enterprise Value
$6.57B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.

The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.

iShares 20 Plus Year Treasury Bond ETF

TLT, the iShares 20+ Year Treasury Bond ETF, trades at $77.87, up 0.94% on the day but remains in a prolonged downtrend, down 11% year-to-date and 46% over five years. The technical picture is bearish with moving averages signaling continued pressure, while oscillators show neutral momentum. Recent news highlights a challenging bond market environment with Treasury yields reaching multi-decade highs, creating headwinds for long-duration bond funds.

The outlook for TLT remains heavily dependent on interest rate direction, with current high yields offering potential income but significant price risk if rates continue rising. Key investment considerations include duration risk exposure, inflation expectations, and Federal Reserve policy shifts. The fund's dividend payments provide income, but capital preservation remains challenging in the current rising rate environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OSCR

No sentiment data available yet.

TLT
44% Buy56% Sell
Avg holding period · 83 Days

Top news

Latest headlines on both assets

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →

About iShares 20 Plus Year Treasury Bond ETF

The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.

Read more on TLT →